首页|Chengdu Fifth People's Hospital Reports Findings in Rectal Cancer (Robotic vs la paroscopic abdominoperineal resection for rectal cancer: A propensity score matc hing cohort study and meta-analysis)
Chengdu Fifth People's Hospital Reports Findings in Rectal Cancer (Robotic vs la paroscopic abdominoperineal resection for rectal cancer: A propensity score matc hing cohort study and meta-analysis)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology - Rectal Canc er is the subject of a report. According to news reporting from Chengdu, People' s Republic of China, by NewsRx journalists, research stated, "Robotic surgery (R S) is gaining popularity; however, evidence for abdominoperineal resection (APR) of rectal cancer (RC) is scarce. To compare the efficacy of RS and laparoscopic surgery (LS) in APR for RC." The news correspondents obtained a quote from the research from Chengdu Fifth Pe ople's Hospital, "We retrospectively identified patients with RC who underwent A PR by RS or LS from April 2016 to June 2022. Data regarding short-term surgical outcomes were compared between the two groups. To reduce the effect of potential confounding factors, propensity score matching was used, with a 1:1 ratio betwe en the RS and LS groups. A meta-analysis of seven trials was performed to compar e the efficacy of robotic and laparoscopic APR for RC surgery. Of 133 patients, after propensity score matching, there were 42 patients in each group. The posto perative complication rate was significantly lower in the RS group (17/42, 40.5% ) than in the LS group (27/42, 64.3%) ( = 0.029). There was no sign ificant difference in operative time ( = 0.564), intraoperative transfusion ( = 0.314), reoperation rate ( = 0.314), lymph nodes harvested ( =0.309), or circum ferential resection margin (CRM) positive rate ( = 0.314) between the two groups . The meta-analysis showed patients in the RS group had fewer positive CRMs ( = 0.04), lesser estimated blood loss (<0.00001), shorter pos toperative hospital stays ( = 0.02), and fewer postoperative complications ( = 0 .002) than patients in the LS group."
ChengduPeople's Republic of ChinaAsi aCancerClinical ResearchClinical Trials and StudiesEmerging TechnologiesGastroenterologyHealth and MedicineMachine LearningOncologyRectal Canc erRoboticsRobotsSurgery
NETL
NSTL
